{"version":"1.0","type":"link","title":"Rezivertinib in -Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study.","author_name":"Yang S 외","author_url":"https://prs-insight.online/author/Yang%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95101","thumbnail_width":1200,"thumbnail_height":630}